2020 | Bacterial Nucleoside Catabolism Controls Quorum Sensing and Commensal-to-Pathogen Transition in the Drosophila Gut | 권영주; 전규연 | Article |
2013 | Bacterial-derived uracil as a modulator of mucosal immunity and gut-microbe homeostasis in drosophila | 권영주 | Article |
2015 | Benzo[b]Tryptanthrin Inhibits MDR1, Topoisomerase Activity, and Reverses Adriamycin Resistance in Breast Cancer Cells | 권영주; 전규연 | Article |
2017 | BMI-1 interacts with sMEK1 and inactivates sMEK1-induced apoptotic cell death | 김보람 | Master's Thesis |
2017 | BMI-1 interacts with sMEK1 and inactivates sMEK1-induced apoptotic cell death | 권영주 | Article |
2014 | BPM-5d; Synthesized Novel Dual Inhibitor Targeting Human Epidermal Growth Factor Receptor 2 and Topoisomerase IIα with Potent Anticancer Activity in Trastuzumab-Resistant Colon Cancer Cells | 우현정 | Master's Thesis |
2014 | Ca2+-mediated Translocation of m-Calpain Induces Ku80 Cleavage and Enhances Ku80-related DNA Repair Pathway | 백경혜 | Master's Thesis |
2016 | Calcium influx-mediated translocation of m-calpain induces Ku80 cleavage and enhances the Ku80-related DNA repair pathway | 권영주 | Article |
2023 | Cannabidiol, a Regulator of Intracellular Calcium and Calpain | 권영주; 전경화 | Article |
2018 | Causes of hyperhomocysteinemia and its pathological significance | 권영주 | Review |
2023 | Cervi Parvum Cornu complex for men with lower urinary tract symptoms: a multicenter, randomized, double-blind, placebo-controlled trial | 권영주; 전경화 | Article |
2011 | Chalcones as novel non-peptidic μ-calpain inhibitors | 권영주 | Article |
2013 | Chalcones, inhibitors for topoisomerase i and cathepsin B and L, as potential anti-cancer agents | 권영주 | Article |
2014 | Cobalt-albumin binding (CAB) assay: An advantageous and flaw free testing of albumin-cobalt binding | 권영주 | Article |
2007 | Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA-topoisomerase I complex | 권영주 | Article |
2021 | COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development | 권영주 | Review |
2014 | Curcumin as a cancer chemotherapy sensitizing agent | 권영주 | Review |
2011 | Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein | 김화정; 이경림; 권영주; 맹지혜 | Article |
2011 | Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase i inhibitors with molecular modeling | 권영주 | Article |
2015 | Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents | 권영주; 전규연 | Article |
2015 | Design and synthesis of novel 2,4-diaryl-5H-indeno[1,2-b]pyridine derivatives, and their evaluation of topoisomerase inhibitory activity and cytotoxicity | 권영주 | Article |
2007 | Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors | 이상국; 권영주 | Article |
2017 | Design, synthesis and biological evaluation of 1,3-diphenylbenzo[f] [1,7]naphthyrdines | 권영주; 전규연 | Article |
2011 | Design, synthesis and docking study of 5-amino substituted indeno[1,2-c]isoquinolines as novel topoisomerase i inhibitors | 권영주 | Article |
2014 | Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors | 권영주 | Article |
2012 | Design, synthesis, and antitumor evaluation of 2,4,6-triaryl pyridines containing chlorophenyl and phenolic moiety | 권영주 | Article |
2018 | Design, synthesis, and biological evaluation of 1,3-diarylisoquinolines as novel topoisomerase I catalytic inhibitors | 권영주 | Article |
2023 | Design, synthesis, and biological evaluation of novel HSP27 inhibitors to sensitize lung cancer cells to clinically available anticancer agents | 권영주; 이윤실; 황수연; 전슬기 | Article |
2022 | Design, Synthesis, and Cytotoxicity and Topoisomerase I/IIα Inhibition Activity of Pyrazolo[4,3-f]quinoline Derivatives | 권영주 | Article |
2018 | Design, synthesis, and structure-activity relationships of new benzofuro [3,2-b]pyridin-7-ols as DNA topoisomerase II inhibitors | 권영주 | Article |